The Becoming of Children With Doose Syndrome
DOOSE
1 other identifier
observational
50
1 country
1
Brief Summary
Doose syndrome is a rare epileptic syndrome that can lead to learning difficulties and a poor quality of life. The goal of this study is to evaluate the evolution of epilepsy and its consequences on cognitive development and learning issues in children with Doose syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 6, 2019
CompletedFirst Posted
Study publicly available on registry
August 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedApril 12, 2023
April 1, 2023
4.3 years
August 6, 2019
April 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
disease effects on the learning ability of children with doose syndrome
disease effects on the learning ability of children with doose syndrome base on scholar informations
day of inclusion
Secondary Outcomes (1)
Evolution of epilepsy in children with doose syndrome based on pathological symptoms
day of inclusion
Interventions
questionnaire send to the parents
Eligibility Criteria
During this study, parents of children with Doose syndrome will receive a questionnaire regarding learning disabilities, quality of life and epilepsy of their children. Children with doose syndrome diagnosed between ages 1 and 6 and with normal development until onset of seizures will be included in this study.
You may qualify if:
- children with doose syndrome diagnosed between ages 1 and 6
- normal development until onset of seizures
You may not qualify if:
- unconfirmed diagnoses
- abnormal diagnoses
- abnormal psychomotor development before onset of seizures
- cerebral MRI abnormalities
- other child epileptic syndromes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Universitaire, Amienslead
- University Hospital, Lillecollaborator
- University Hospital, Rouencollaborator
Study Sites (1)
CHU Amiens
Amiens, 80480, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvie Nguyen, Pr
CHRU LILLE
- PRINCIPAL INVESTIGATOR
Axel Lebas, MD
CHU Rouen
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2019
First Posted
August 7, 2019
Study Start
August 1, 2019
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share